Medtronic (MDT) free cash flow

Free cash flow · fiscal 2026
$5.43B

Medtronic (MDT) generated free cash flow of $5.43B in fiscal 2026 (the year ended April 30, 2026). That is 4.6% higher than the $5.19B of fiscal 2025. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
$5.43B
Change on fiscal 2025
+4.6%
Growth, 5 years
+2.1% a year
Growth, 10 years
+2.7% a year
Highest on record
$6.02Bfiscal 2020
Lowest on record
$3.62Bfiscal 2018
Fiscal years on record
142013–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Medtronic free cash flow, in more detail

Over the five fiscal years to 2026 free cash flow grew at a compound 2.1% a year; over ten years the rate was 2.7% a year. Across the 14 fiscal years on record (2013–2026), the highest was $6.02B in fiscal 2020 and the lowest $3.62B in fiscal 2018.

History · 14 fiscal years

Free cash flow by fiscal year

Medtronic free cash flow, year by year

Medtronic (MDT) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026$5.43B 4.6% up
2025$5.19B 0.3% down
2024$5.20B 13.5% up
2023$4.58B 23.4% down
2022$5.98B 22.4% up
2021$4.89B 18.9% down
2020$6.02B 2.5% up
2019$5.87B 62.4% up
2018$3.62B 35.7% down
2017$5.63B 34.9% up
2016$4.17B 3.7% down
2015$4.33B 5.1% down
2014$4.56B 1.7% up
2013$4.49B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Medtronic and comparable companies
CompanyFree cash flowFiscal year
Vertex Pharmaceuticals VRTX$3.19B2025
Medtronic MDT$5.43B2026
Bristol-Myers Squibb BMY$12.85B2025
Stryker SYK$4.28B2025
McKesson MCK$5.41B2026
Sanofi SNY€7.21B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MDT

Medtronic, figure by figure

Medtronic (MDT) overview: price, valuation and scorecardAll health care companies by market value

Medtronic free cash flow: questions and answers

What is Medtronic's free cash flow?

Medtronic (MDT) generated free cash flow of $5.43B in fiscal 2026 (the year ended April 30, 2026). That is 4.6% higher than the $5.19B of fiscal 2025.

What is the growth rate of Medtronic's free cash flow?

Over the five fiscal years to 2026 free cash flow grew at a compound 2.1% a year; over ten years the rate was 2.7% a year.

What are the highest and lowest free cash flow figures on record for Medtronic?

Across the 14 fiscal years on record (2013–2026), the highest was $6.02B in fiscal 2020 and the lowest $3.62B in fiscal 2018.

How is Medtronic's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Medtronic it is on record here for 14 fiscal years, 2013 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Medtronic (MDT) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/MDT/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.